H.Res. 803 · 119th Congress
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
- Stage
- In committee
- Sponsor
- John Rose
- Introduced
- 2025-10-10
- Latest action
- 2025-10-10 · Submitted in House
Action history
- 2025-10-10Submitted in House
- 2025-10-10Referred to the House Committee on Energy and Commerce.